Post by selluwud on Dec 12, 2016 16:14:04 GMT
I had this issue on my radar/watch list for some time but I never invested. They were conducting a clinical trial for Wet AMD which failed to meet endpoints. The stock was down over 80% when it opened, just goes to show how risky and volatile investing in biotechs can be.